Computer-Based Therapy for Mild Cognitive Impairment
Study Details
Study Description
Brief Summary
The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild cognitive impairment (MCI).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Detailed Description
The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and cognitive function following computer training, 2) to investigate the neurophysiological mechanisms underlying such neuropsychological improvements, and 3) to demonstrate the feasibility of using this kind of computer-based therapy in older populations.
Study Design
Outcome Measures
Primary Outcome Measures
- The study investigates changes in a neuropsychological assessment battery pre-randomization []
- and upon the completion of training. []
Secondary Outcome Measures
- Early evaluations will be conducted from brain imaging; specifically, date []
- obtained via positron emission tomography (PET), magnetoencephalography (MEG), []
- electroencephalography (EEG), and functional magnetic resonance imaging (fMRI) []
- studies. []
Eligibility Criteria
Criteria
Inclusion Criteria:
1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.
3)Fluency in English 4)Willing to meet the time commitment of the study
-
Exclusion Criteria:
-
Clinically significant cerebrovascular disease
-
Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of California, San Francisco | San Francisco | California | United States | 94143 |
Sponsors and Collaborators
- Posit Science Corporation
- University of California, San Francisco
- University of California, Davis
- Stanford University
Investigators
- Principal Investigator: Joel Kramer, PsyD, University of California, San Francisco
Study Documents (Full-Text)
None provided.More Information
Publications
- OUT-108-2005